CO2017005806A2 - Nuevos derivados de bencimidazol como agentes antihistamínicos - Google Patents

Nuevos derivados de bencimidazol como agentes antihistamínicos

Info

Publication number
CO2017005806A2
CO2017005806A2 CONC2017/0005806A CO2017005806A CO2017005806A2 CO 2017005806 A2 CO2017005806 A2 CO 2017005806A2 CO 2017005806 A CO2017005806 A CO 2017005806A CO 2017005806 A2 CO2017005806 A2 CO 2017005806A2
Authority
CO
Colombia
Prior art keywords
benzimidazole derivatives
antihistamine agents
new benzimidazole
compounds
formula
Prior art date
Application number
CONC2017/0005806A
Other languages
English (en)
Inventor
Herrero Gonzalo Hernández
Solanes Rosa Rodes
Tizne Roberto Olivera
Royo Víctor Rubio
GÓMEZ Francisco LEDO
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of CO2017005806A2 publication Critical patent/CO2017005806A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a compuestos de fórmula (I): (Formula I) o una sal o un solvato farmacéuticamente aceptable de los mismos, a un método de síntesis de dichos compuestos, a composiciones farmacéuticas que comprenden los mismos y a su uso en el tratamiento y/o la prevención de estados mediados por el receptor histamínico H1, tales como enfermedades o trastornos alérgicos.
CONC2017/0005806A 2014-12-29 2017-06-13 Nuevos derivados de bencimidazol como agentes antihistamínicos CO2017005806A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382576.8A EP3040334A1 (en) 2014-12-29 2014-12-29 New benzimidazole derivatives as antihistamine agents
PCT/EP2015/081292 WO2016107848A1 (en) 2014-12-29 2015-12-28 New benzimidazole derivatives as antihistamine agents

Publications (1)

Publication Number Publication Date
CO2017005806A2 true CO2017005806A2 (es) 2017-09-20

Family

ID=52302107

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0005806A CO2017005806A2 (es) 2014-12-29 2017-06-13 Nuevos derivados de bencimidazol como agentes antihistamínicos

Country Status (17)

Country Link
US (1) US10106522B2 (es)
EP (2) EP3040334A1 (es)
JP (1) JP6585718B2 (es)
KR (1) KR20170097669A (es)
CN (1) CN107108575B (es)
AU (1) AU2015373457B2 (es)
BR (1) BR112017013998A2 (es)
CA (1) CA2970854A1 (es)
CL (1) CL2017001720A1 (es)
CO (1) CO2017005806A2 (es)
EA (1) EA033827B1 (es)
ES (1) ES2706475T3 (es)
MX (1) MX371102B (es)
PE (1) PE20171089A1 (es)
PT (1) PT3240783T (es)
WO (1) WO2016107848A1 (es)
ZA (1) ZA201704462B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
AU2018353360B2 (en) 2017-10-16 2021-04-01 Faes Farma, S.A. Aqueous compositions comprising bilastine and mometasone
JP7309729B2 (ja) 2018-01-18 2023-07-18 ファエス・ファルマ・ソシエダッド・アノニマ ビラスチン、β－シクロデキストリンおよび少なくとも１種のゲル化剤を含有する眼科用組成物
DE102019211434B3 (de) 2019-07-31 2020-11-05 Premium Aerotec Gmbh Spantkomponente und verfahren zur herstellung einer spantkomponente, spant und rumpfstruktur für ein luftfahrzeug
WO2023156559A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238863A (en) * 1990-07-19 1993-03-26 Janssen Pharmaceutica Nv Substituted thiazolyl and pyridinyl derivatives
ES2048109B1 (es) 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2124167B1 (es) 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
JP2001011050A (ja) * 1999-04-30 2001-01-16 Sankyo Co Ltd 含窒素飽和複素環化合物
WO2002034719A1 (fr) * 2000-04-21 2002-05-02 Sankyo Company, Limited Composes heterocycliques azotes satures
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2002212683A1 (en) * 2000-10-30 2002-05-15 Sankyo Company, Limited Preventive or therapeutic medicines for hepatitis and/or hepatopathy
JP2002322059A (ja) * 2001-04-25 2002-11-08 Sankyo Co Ltd 炎症性腸疾患の予防又は治療剤
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents

Also Published As

Publication number Publication date
CA2970854A1 (en) 2016-07-07
PE20171089A1 (es) 2017-08-03
CL2017001720A1 (es) 2018-03-16
US10106522B2 (en) 2018-10-23
JP6585718B2 (ja) 2019-10-02
MX2017008495A (es) 2017-09-19
ES2706475T3 (es) 2019-03-29
WO2016107848A1 (en) 2016-07-07
PT3240783T (pt) 2019-01-28
JP2018502075A (ja) 2018-01-25
EP3240783A1 (en) 2017-11-08
KR20170097669A (ko) 2017-08-28
EA201791480A1 (ru) 2017-11-30
EP3040334A1 (en) 2016-07-06
BR112017013998A2 (pt) 2018-03-06
AU2015373457B2 (en) 2019-09-19
AU2015373457A1 (en) 2017-07-27
US20180016251A1 (en) 2018-01-18
CN107108575B (zh) 2019-07-26
EA033827B1 (ru) 2019-11-29
MX371102B (es) 2020-01-16
ZA201704462B (en) 2019-09-25
EP3240783B1 (en) 2018-11-21
CN107108575A (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
CO2017004525A2 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
ECSP16076566A (es) Compuestos de heteroarilo o arilo biciclicos fusionados y su aplicación a inhibidores de irak4
CO2017012267A2 (es) Compuestos de naftiridina como inhibidores de la quinasa jak
CU20170154A7 (es) Derivados de pirazol-3-il-amina sustituidos como inhibidores cdk
CO2017005806A2 (es) Nuevos derivados de bencimidazol como agentes antihistamínicos
CL2020001218A1 (es) Compuestos útiles para inhibir a cdk7.
CR20150628A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
UY36342A (es) Nuevos derivados de aminoalquilbenzotiazepinas y usos de los mismos
ECSP17007208A (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
CO6741217A2 (es) Modulares de receptor de glucagón
EA201692249A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
EA201692265A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
MX2017002816A (es) Derivados de pirazolopiridina y su uso en terapia.
SV2016005313A (es) Derivados de carboxamida
UY37837A (es) Nuevos compuestos heterocíclicos como inhibidores de cdk8/19
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
UY36123A (es) Derivados de carboxamida
MX2020003732A (es) Derivado de anillo fusionado como inhibidor del receptor a2a.
CR20180091A (es) 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del vih
NI201600091A (es) UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS
ECSP21010874A (es) Piridopirimidinas como inhibidores del receptor de histamina h4
UY33745A (es) Derivados de difenilamina: usos, procedimiento de síntesis y composiciones farmacéuticas
UY36084A (es) Activadores de herg policíclicos
DOP2017000138A (es) Derivados de fumagilol
CL2017002605A1 (es) Derivados de indol